MIT conference reveals the power of using artificial intelligence to discover new drugs
Inaugural AI Powered Drug Discovery and Manufacturing Conference drew pharmaceutical companies, government regulators, and pioneering drug researchers.
Search Stories
With lidar and artificial intelligence, road status clears up after a disaster
Automated tools can help emergency managers make decisions, plan routes, and quantify road damage at city scales.
MIT team races to fill Covid-19-related ventilator shortage
An ad hoc team of engineers and doctors has developed a low-cost, open-source alternative, now ready for rapid production.
3 Questions: Charles Stewart on the Covid-19 pandemic’s impact on the 2020 elections
Head of the MIT Election Data and Science Lab discusses the greatest risks, voting by mail, zombies, and asteroids.
3 Questions: Catherine D’Ignazio on visualizing Covid-19 data
“Data scientists and visualization designers need to take their civic role very seriously in a pandemic,” says the MIT assistant professor.
Safe Paths: A privacy-first approach to contact tracing
A multinational team develops new tools to slow the spread of pandemics.
Gamma radiation found ineffective in sterilizing N95 masks
Nuclear scientists and biomedical researchers team up to investigate whether treatment with gamma radiation could make N95 masks more reusable.
Evaluating the global energy system
Meet the team of postdocs developing the MIT Energy Initiative's energy life-cycle assessment tool.
Katie Collins, Vaishnavi Phadnis, and Vaibhavi Shah named 2020-21 Goldwater Scholars
Three MIT undergraduates who use computer science to explore human biology and health honored for their academic achievements.
Accelerating data-driven discoveries
Life science companies use Paradigm4’s unique database management system to uncover new insights into human health.
3 Questions: Greg Britten on how marine life can recover by 2050
Committing to aggressive conservation efforts could rebuild ocean habitats and species populations in a few decades.
MIT-affiliated companies take on Covid-19
A variety of companies with MIT ties are working to address aspects of the Covid-19 pandemic.
![“Most manufacturing companies will keep about two weeks of inventory,” says David Simchi-Levi, who is a professor of engineering systems in the School of Engineering and in the Institute for Data, Systems, and Society within the MIT Stephen A. Schwarzman College of Computing. "That means they were able to cover demand for the first two weeks of March. After that, [given] no more supplies, ther...](/sites/default/files/styles/search_result_item/public/images/202003/MIT-SupplyChain-Simchi-Levi-01.jpg?itok=bv-zMBSs)
Supply chain outlook: The timing of the slowdown
MIT Professor David Simchi-Levi forecast the mid-March manufacturing pause. Now he looks ahead.
3Q: Collaborating with users to develop accessible designs
An MIT team discusses the pitfalls of “parachute research” and the importance of “sociotechnical” factors.
Why are workers getting smaller pieces of the pie?
Market concentration in the form of “superstar” firms has been lowering labor’s share of GDP in recent decades, a new study finds.